The product will be sold and distributed by Founder Pharma in China.
Perrigo chairman and CEO Joseph C Papa said Synthetic’s strong brand, marketing, and distribution would help them grow in the robust infant formula market.
Perrigo Company develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API).